Impact on health-related quality of life of the addition of bevacizumab to cisplatin-pemetrexed in malignant pleural mesothelioma in the MAPS phase III trial

  • Etude concernée: MAPS
  • Auteurs / Authors: Virginie Westeel, Guillaume Eberst, Amelie Anota, Arnaud Scherpereel, Julien Mazieres, Jacques Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Olivier Molinier, Lena Herve, Frédéric Rivière, Isabelle Monnet, Valérie Gounant, Henri Janicot, Radj Gervais, Chrystele Locher, Franck Morin, Gerard Zalcman, French Cooperative Thoracic Intergroup (IFCT)
  • Journal / Conference: ASCO
  • Année / Year: 2018
  • PMID: Oral abstract
  • Lien vers la publication: https://meetinglibrary.asco.org/record/160037/abstract